HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients

Autor: Mary Clare Cathcart, Ronan Feighery, Jenny A. Watson, Margaret R. Dunne, Naoimh J. O’Farrell, Narayanasamy Ravi, John V. Reynolds, Brendan Doyle, Adriana J. Michielsen, Jacintha O'Sullivan, Elizabeth J. Ryan, Katie E. O’Sullivan, Elaine W. Kay
Jazyk: angličtina
Předmět:
0301 basic medicine
Oncology
Male
Cancer Research
Inflammation-associated cancer
Survival
Esophageal Neoplasms
Kaplan-Meier Estimate
Prognostic markers
0302 clinical medicine
Barrett’s esophagus
Esophagitis
Immunology and Allergy
Aged
80 and over

Tissue microarray
Middle Aged
Prognosis
Immunohistochemistry
medicine.anatomical_structure
030220 oncology & carcinogenesis
Disease Progression
Adenocarcinoma
Original Article
Female
Esophageal adenocarcinoma
Adult
medicine.medical_specialty
Immunology
03 medical and health sciences
Barrett Esophagus
Esophagus
Internal medicine
medicine
Biomarkers
Tumor

Humans
Aged
business.industry
HLA-DR
Cancer
Epithelial Cells
HLA-DR Antigens
medicine.disease
Epithelium
030104 developmental biology
Dysplasia
Tissue Array Analysis
Barrett's esophagus
Stromal Cells
business
Precancerous Conditions
Zdroj: Cancer Immunology, Immunotherapy
ISSN: 0340-7004
DOI: 10.1007/s00262-017-1983-1
Popis: Esophageal adenocarcinoma (EAC) is an aggressive cancer with poor prognosis, and incidence is increasing rapidly in the Western world. Measurement of immune markers has been shown to have prognostic significance in a growing number of cancers, but whether this is true for EAC has yet to be evaluated. This study aimed to characterize HLA-DR expression in the esophagus across the inflammation to cancer progression sequence and to assess the prognostic significance of HLA-DR expression in EAC. Tissue microarrays (TMA) were constructed from esophageal tissue taken from patients at different stages in the cancer progression sequence; normal, esophagitis, Barrett’s esophagus (BE), low- and high-grade dysplasia (LGD, HGD) and EAC. HLA-DR expression in tissue epithelium and stroma was assessed by immunohistochemistry. HLA-DR expression increased early in the inflammation to cancer progression sequence; with higher expression detected in esophagitis and BE compared to normal tissue. Patients with low (
Databáze: OpenAIRE